Multimodality Approaches to Localized Gastric Cancer

Restricted access

Most patients with localized gastric cancer require multimodality therapy. Surgery is the primary treatment for localized gastric cancer, although controversy exists about the optimal extent of lymphadenectomy in these patients. Recent studies have evaluated the role of laparoscopic surgery and endoscopic mucosal resection in selected patients. Multimodality treatment options for these patients include post-operative chemoradiation and perioperative chemotherapy. The Intergroup 0116 trial demonstrated that patients treated with surgery and post-operative chemoradiation had significantly higher overall survival compared to patients treated with surgery alone. The MAGIC trial showed that patients treated with perioperative epirubicin, cisplatin, and 5-fluorouracil had significantly higher overall survival compared to patients treated with surgery alone. Other recent trials have evaluated the roles of preoperative chemoradiation and adjuvant chemotherapy. Multidisciplinary evaluation plays a crucial role in the management of these patients.

Correspondence: Prajnan Das, MD, MS, MPH, Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030. E-mail: PrajDas@mdanderson.org

Made equal contributions to the manuscript.

  • 1.

    JemalASiegelRWardE. Cancer statistics, 2009. CA Cancer J Clin2009;59:225249.

  • 2.

    DevesaSSBlotWJFraumeniJFJr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer1998;83:20492053.

    • Search Google Scholar
    • Export Citation
  • 3.

    BrownLMDevesaSSChowWH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst2008;100:11841187.

    • Search Google Scholar
    • Export Citation
  • 4.

    ParkinDMBrayFFerlayJPisaniP. Global cancer statistics, 2002. CA Cancer J Clin2005;55:74108.

  • 5.

    KarpehMSLeonLKlimstraDBrennanMF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1,038 patients. Ann Surg2000;232:362371.

    • Search Google Scholar
    • Export Citation
  • 6.

    RoderJDBottcherKBuschR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer1998;82:621631.

    • Search Google Scholar
    • Export Citation
  • 7.

    GanpathiISSoJBHoKY. Endoscopic ultrasonography for gastric cancer: does it influence treatment?Surg Endosc2006;20:559562.

  • 8.

    AhnHSLeeHJYooMW. Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer. J Surg Oncol2009;99:2027.

    • Search Google Scholar
    • Export Citation
  • 9.

    LightdaleCJKulkarniKG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol2005;23:44834489.

    • Search Google Scholar
    • Export Citation
  • 10.

    LimJSYunMJKimMJ. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics2006;26:143156.

    • Search Google Scholar
    • Export Citation
  • 11.

    ChenJCheongJHYunMJ. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer2005;103:23832390.

    • Search Google Scholar
    • Export Citation
  • 12.

    StahlAOttKWeberWA. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging2003;30:288295.

    • Search Google Scholar
    • Export Citation
  • 13.

    BentremDWiltonAMazumdarM. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol2005;12:347353.

    • Search Google Scholar
    • Export Citation
  • 14.

    BadgwellBCormierJNKrishnanS. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?Ann Surg Oncol2008;15:26842691.

    • Search Google Scholar
    • Export Citation
  • 15.

    PistersPWTKelsenDPPowellSMTepperJE. Cancer of the stomach. In: DeVita VT Hellman S Rosenberg SA eds.Cancer: Principles & Practice of Oncology. Philadelphia: Lippincott; 2005:909944.

    • Search Google Scholar
    • Export Citation
  • 16.

    RobertsonCSChungSCWoodsSD. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg1994;220:176182.

    • Search Google Scholar
    • Export Citation
  • 17.

    GouziJLHuguierMFagniezPL. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg1989;209:162166.

    • Search Google Scholar
    • Export Citation
  • 18.

    BozzettiFMarubiniEBonfantiG. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg1999;230:170178.

    • Search Google Scholar
    • Export Citation
  • 19.

    Cancer AJCo.AJCC Cancer Staging Handbook 6th ed.New York: Springer Verlag; 2002.

  • 20.

    MaruyamaKGunvenPOkabayashiK. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg1989;210:596602.

  • 21.

    SmithDDSchwarzRRSchwarzRE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol2005;23:71147124.

    • Search Google Scholar
    • Export Citation
  • 22.

    BonenkampJJHermansJSasakoMvan de VeldeCJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med1999;340:908914.

    • Search Google Scholar
    • Export Citation
  • 23.

    CuschieriAWeedenSFieldingJ. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer1999;79:15221530.

    • Search Google Scholar
    • Export Citation
  • 24.

    WuCWHsiungCALoSS. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol2006;7:309315.

  • 25.

    SasakoMSanoTYamamotoS. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med2008;359:453462.

    • Search Google Scholar
    • Export Citation
  • 26.

    PeetersKCHundahlSAKranenbargEK. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg2005;29:15761584.

    • Search Google Scholar
    • Export Citation
  • 27.

    StrongVEDevaudNKarpehM. The role of laparoscopy for gastric surgery in the west. Gastric Cancer2009;12:127131.

  • 28.

    KitanoSShiraishiNUyamaI. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg2007;245:6872.

    • Search Google Scholar
    • Export Citation
  • 29.

    JeongGAChoGSKimHH. Laparoscopy-assisted total gastrectomy for gastric cancer: a multicenter retrospective analysis. Surgery2009;146:469474.

    • Search Google Scholar
    • Export Citation
  • 30.

    SoetiknoRKaltenbachTYehRGotodaT. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol2005;23:44904498.

    • Search Google Scholar
    • Export Citation
  • 31.

    TakekoshiTBabaYOtaH. Endoscopic resection of early gastric carcinoma: results of a retrospective analysis of 308 cases. Endoscopy1994;26:352358.

    • Search Google Scholar
    • Export Citation
  • 32.

    AbeNWatanabeTSugiyamaM. Endoscopic treatment or surgery for undifferentiated early gastric cancer?Am J Surg2004;188:181184.

  • 33.

    ParkYDChungYJChungHY. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Endoscopy2008;40:710.

    • Search Google Scholar
    • Export Citation
  • 34.

    BirkmeyerNJGoodneyPPStukelTA. Do cancer centers designated by the National Cancer Institute have better surgical outcomes?Cancer2005;103:435441.

    • Search Google Scholar
    • Export Citation
  • 35.

    SmithDLEltingLSLearnPA. Factors influencing the volume-outcome relationship in gastrectomies: a population-based study. Ann Surg Oncol2007;14:18461852.

    • Search Google Scholar
    • Export Citation
  • 36.

    BirkmeyerJDSunYGoldfadenA. Volume and process of care in high-risk cancer surgery. Cancer2006;106:24762481.

  • 37.

    MacdonaldJSSmalleySRBenedettiJ. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med2001;345:725730.

    • Search Google Scholar
    • Export Citation
  • 38.

    HundahlSAMacdonaldJSBenedettiJFitzsimmonsT. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol2002;9:278286.

    • Search Google Scholar
    • Export Citation
  • 39.

    KimSLimDHLeeJ. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys2005;63:12791285.

    • Search Google Scholar
    • Export Citation
  • 40.

    CoburnNGGovindarajanALawCH. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients. Ann Surg Oncol2008;15:500507.

    • Search Google Scholar
    • Export Citation
  • 41.

    KozakKRMoodyJS. The survival impact of the intergroup 0116 trial on patients with gastric cancer. Int J Radiat Oncol Biol Phys2008;72:517521.

    • Search Google Scholar
    • Export Citation
  • 42.

    SmalleySRGundersonLTepperJ. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys2002;52:283293.

    • Search Google Scholar
    • Export Citation
  • 43.

    McCloskeySAYangGY. Benefits and challenges of radiation therapy in gastric cancer: techniques for improving outcomes. Gastrointest Cancer Res2009;3:1519.

    • Search Google Scholar
    • Export Citation
  • 44.

    ZhangZXGuXZYinWB. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)—report on 370 patients. Int J Radiat Oncol Biol Phys1998;42:929934.

    • Search Google Scholar
    • Export Citation
  • 45.

    FioricaFCarteiFEneaM. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev2007;33:729740.

    • Search Google Scholar
    • Export Citation
  • 46.

    AjaniJAMansfieldPFJanjanN. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol2004;22:27742780.

    • Search Google Scholar
    • Export Citation
  • 47.

    AjaniJAMansfieldPFCraneCH. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol2005;23:12371244.

    • Search Google Scholar
    • Export Citation
  • 48.

    OkawaraGSWinterKDonohueJH. A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99-04) [abstract]. J Clin Oncol2005;23(Suppl 1):Abstract 4019.

    • Search Google Scholar
    • Export Citation
  • 49.

    RiveraFGalanMTaberneroJ. Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. Int J Radiat Oncol Biol Phys2009;75:14301436.

    • Search Google Scholar
    • Export Citation
  • 50.

    WydmanskiJSuwinskiRPoltorakS. The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study. Radiother Oncol2007;82:132136.

    • Search Google Scholar
    • Export Citation
  • 51.

    StahlMWalzMKStuschkeM. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol2009;27:851856.

    • Search Google Scholar
    • Export Citation
  • 52.

    NordlingerBSorbyeHColletteL. Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases [abstract]. J Clin Oncol2007;25(Suppl 1):Abstract LBA5.

    • Search Google Scholar
    • Export Citation
  • 53.

    IgakiHKatoHAndoN. A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907) [abstract]. J Clin Oncol2008;26(Suppl 1):Abstract 4510.

    • Search Google Scholar
    • Export Citation
  • 54.

    CunninghamDAllumWHStenningSP. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med2006;355:1120.

    • Search Google Scholar
    • Export Citation
  • 55.

    TsavarisNTentasKKosmidisP. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. Chemotherapy1996;42:220226.

    • Search Google Scholar
    • Export Citation
  • 56.

    EarleCCMarounJA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer1999;35:10591064.

    • Search Google Scholar
    • Export Citation
  • 57.

    JanungerKGHafstromLGlimeliusB. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg2002;168:597608.

  • 58.

    MariEFlorianiITinazziA. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a metaanalysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol2000;11:837843.

    • Search Google Scholar
    • Export Citation
  • 59.

    PanziniIGianniLFattoriPP. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori2002;88:2127.

    • Search Google Scholar
    • Export Citation
  • 60.

    HermansJBonenkampJJBoonMC. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol1993;11:14411447.

    • Search Google Scholar
    • Export Citation
  • 61.

    SakuramotoSSasakoMYamaguchiT. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med2007;357:18101820.

    • Search Google Scholar
    • Export Citation
  • 62.

    AjaniJARodriquezWBodokyG. Multicenter phase III comparison of cisplatin/S-1 (CS) with cisplatin/5-FU (CF) as first-line therapy in patients with advanced gastric cancer (FLAGS): secondary and subset analyses [abstract]. J Clin Oncol2009;27(Suppl 1):Abstract 4511.

    • Search Google Scholar
    • Export Citation
  • 63.

    LeeJKangWLimD. Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): safety analysis [abstract]. J Clin Oncol2009;27(Suppl 1):Abstract 5.

    • Search Google Scholar
    • Export Citation
  • 64.

    ImanagaHNakazatoH. Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg1977;2:213221.

    • Search Google Scholar
    • Export Citation
  • 65.

    GrauJJEstapeJFusterJ. Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer. J Clin Oncol1998;16:10361039.

    • Search Google Scholar
    • Export Citation
  • 66.

    OchiaiTSatoHHayashiR. Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative gastric cancer patients. Cancer Res1983;43:30013007.

    • Search Google Scholar
    • Export Citation
  • 67.

    HamazoeRMaetaMKaibaraN. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer1994;73:20482052.

    • Search Google Scholar
    • Export Citation
  • 68.

    NakajimaTTakahashiTTakagiK. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol1984;2:13661371.

    • Search Google Scholar
    • Export Citation
  • 69.

    MaeharaYMoriguchiSSakaguchiY. Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection. J Surg Oncol1990;45:169172.

    • Search Google Scholar
    • Export Citation
  • 70.

    EstapeJGrauJJLcobendasF. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up. Ann Surg1991;213:219221.

    • Search Google Scholar
    • Export Citation
  • 71.

    NeriBde LeonardisVRomanoS. Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Br J Cancer1996;73:549552.

    • Search Google Scholar
    • Export Citation
  • 72.

    SakuramotoSSasakoMYamaguchiT. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med2007;357:18101820.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 45 45 3
PDF Downloads 6 6 0
EPUB Downloads 0 0 0